Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of Arabidopsis treated with silwet for varying time and high throughout haplotyping and single feature polymorphism markers in Arabidopsis
The study of natural genetic variation for plant disease resistance responses is a complementary approach to utilizing mutants to elucidate genetic pathways. While some key genes involved in pathways controlling disease resistance, and signaling intermediates such as salicylic acid (SA) and jasmoni...
ORGANISM(S): Arabidopsis thaliana 
2007-01-01 | E-TABM-61 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of Arabidopsis treated with silwet for varying time and high throughout haplotyping and single feature polymorphism markers in Arabidopsis
The study of natural genetic variation for plant disease resistance responses is a complementary approach to utilizing mutants to elucidate genetic pathways. While some key genes involved in pathways controlling disease resistance, and signaling intermediates such as salicylic acid (SA) and jasmoni...
ORGANISM(S): Arabidopsis thaliana 
2006-11-14 | E-TABM-60 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of expression diversity in Arabidopsis thaliana
The study of natural genetic variation for plant disease resistance responses is a complementary approach to utilizing mutants to elucidate genetic pathways. While some key genes involved in pathways controlling disease resistance, and signaling intermediates such as salicylic acid and jasmonic aci...
ORGANISM(S): Arabidopsis thaliana 
2005-10-26 | E-TABM-51 | biostudies-arrayexpress
UnknownStomach cancer risk after treatment for hodgkin lymphoma.
Not available
S-EPMC3770865 | biostudies-literature
TranscriptomicsTranscription profiling of 148 Arabidopsis recombinant inbred lines treated with Silwet solution to develop genetic markers and derive high-density haplotypes
The study of natural genetic variation for plant disease resistance responses is a complementary approach to utilizing mutants to elucidate genetic pathways. While some key genes involved in pathways controlling disease resistance, and signaling intermediates such as salicylic acid (SA) and jasmoni...
ORGANISM(S): Arabidopsis thaliana 
2007-01-10 | E-TABM-62 | biostudies-arrayexpress
UnknownData evidencing slow anaerobic digestion in emergency treatment and disposal of infectious animal carcasses.
Not available
S-EPMC6302243 | biostudies-literature
TranscriptomicsTranscription profiling of 211 Arabidopsis recombinant inbred lines treated with Silwet solution to identify regulatory quantitative trait loci
The study of natural genetic variation for plant disease resistance responses is a complementary approach to utilizing mutants to elucidate genetic pathways. While some key genes involved in pathways controlling disease resistance, and signaling intermediates such as salicylic acid (SA) and jasmoni...
ORGANISM(S): Arabidopsis thaliana 
2007-04-11 | E-TABM-126 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of Arabidopsis recombinant strains - control hybridizations
The study of natural genetic variation for plant disease resistance responses is a complementary approach to utilizing mutants to elucidate genetic pathways. While some key genes involved in pathways controlling disease resistance, and signaling intermediates such as salicylic acid (SA) and jasmoni...
ORGANISM(S): Arabidopsis thaliana 
2007-03-01 | E-TABM-224 | biostudies-arrayexpress
TranscriptomicsComparing the transcriptome profiling of ob/ob mice treated with the GLP-1 receptor agonist liraglutide, a clinically used GLP-1 receptor agonist, versus baseline controls
B6.Cg-Lep ob/ob mice females were surgically implanted in an age of 10-12 weeks with Alzet osmotic mini pumps (model 1002, 0,25l/h, Cupertino, CA, USA) in two groups of ten mice each to perform continuous subcutaneous infusions of Dulbecco's phosphate buffered saline (vehicle; n = 8) or GLP-1 (GLP-1...
ORGANISM(S): Mus musculus 
2017-09-03 | E-MTAB-6015 | biostudies-arrayexpress
UnknownBreast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.
Not available
S-EPMC3387216 | biostudies-literature
Sort   by:  
 Page size